Your institution may have access to this item. Find your institution then sign in to continue.
Title
Takeda moves into stem cells.
Abstract
The article reports that the pharmaceutical company Takeda Pharmaceutical Co. Ltd. and Center for induced pluripotent stem (iPS) Cell Research Application (CiRA) of Kyoto University announced their $270 million, ten year collaboration for the developing applications of iPS cells.